The change of time sequence gave birth to Huazhang, and spring and Jingming brought good news. On May 9th, 2025, Lishan Biotech Dr. Chen Weijie, Chairman, was awarded the VBEF Annual Innovation Entrepreneur AwardLishan Biotechnology, with its cutting-edge breakthroughs and innovative value in the field of live biopharmaceuticals, has successfully made it onto the list of "2025 Future Medical Top 100" on Arterial Network! This is not only a tribute to the scientific research team's perseverance, but also a full affirmation of the "AI+live biopharmaceutical" innovation track strategy.

As a benchmark for innovation in the healthcare industry, the "Future Medical Top 100" always focuses on non listed companies with the greatest growth potential. The selection of Lishan Biotechnology marks the industry's recognition of its leading position in the field of AI driven new biopharmaceuticals, highlighting Lishan's broad prospects in the "AI+live biopharmaceutical" track.

Live image of award ceremony

Microecological science has moved from the past 'deep valley orchid' to the public eye. With the in-depth analysis of the function of the gut's' second brain 'in academia, the value of its microecological regulation in disease prevention and treatment continues to emerge. Lishan Biotech focuses on the interaction mechanism between gut microbiota and hosts, and is committed to developing personalized diagnosis and treatment solutions based on artificial intelligence through interdisciplinary technology integration, providing innovative practical paths for precision medicine.

Dr. Chen Weijie has studied under two Nobel laureates: Professor Eiichi Negishi, the 2010 Nobel laureate in Chemistry, at Purdue University, where he received a Bachelor's degree in Physics with the highest honor; Transfer to Brown University to study under Professor Michael Kosterlitz, the 2016 Nobel Prize winner in Physics, and complete a Master's degree in Physics and a PhD in Biophysics. In the dual training of Brown University and Albert Einstein College of Medicine, under the guidance of renowned professors Sridhar Mani&Jay Tang, a knowledge matrix spanning biophysics, microbiology, immunology, and artificial intelligence was established, laying a multidimensional cognitive foundation for him to explore the blue ocean of "AI+live biopharmaceuticals".

Dr. Chen Weijie's Award Presentation

Dr. Chen Weijie was awarded the VBEF2025 Future Medical Top 100 Annual Innovative Entrepreneur Award, which is not only an authoritative certification of Lishan Biotechnology's innovative achievements in the industry, but also a clarion call for the future. Standing at a new starting point, Lishan Biotech will continue to write new legends in the vast ocean of life sciences with the dual engines of "AI drug discovery and clinical validation+live biopharmaceuticals".